Literature DB >> 30412513

Vestibular rehabilitation has positive effects on balance, fatigue and activities of daily living in highly disabled multiple sclerosis people: A preliminary randomized controlled trial.

Marco Tramontano1, Alex Martino Cinnera2, Leonardo Manzari3, Federico Francesco Tozzi2,4, Carlo Caltagirone2,5, Giovanni Morone1, Alessandra Pompa6, Maria Grazia Grasso6.   

Abstract

BACKGROUND: Balance disorders are present in patients with Multiple Sclerosis and part of these disorders could be of vestibular origin. Vestibular Rehabilitation was found to be effective in improving balance in patients with central vestibular dysfunction.
OBJECTIVE: To investigate the clinical effects of vestibular rehabilitation on balance skills and secondly on fatigue and activity of daily living in highly disabled multiple sclerosis people.
METHODS: Thirty hospitalized participants with severe multiple sclerosis (EDSS 6-7) were randomly assigned to the experimental group (15 patients -9F-; mean age 50.64±11.73) and the control group (15 patients -8F-; mean age 45.77±10.91). All patients were evaluated before and after treatment with the Expanded Disability Status Scale, Barthel Index Tinetti Balance and Gait scale, Berg Balance Scale, Fatigue Severity Scale, Two Minute Walking Test and Timed 25-foot walk test. Two follow-ups (i.e., at 30 and 60 days after treatment) were carried out with Barthel Index.
RESULTS: Significant improvement was found in the experimental group with respect to the control group (p <  0,05) in balance, fatigue perception, activities of daily living and short distance gait. No significant improvements were found for gait endurance as measured by Two Minute Walking Test.
CONCLUSIONS: Four weeks of Vestibular Rehabilitation training results in less fatigue, improved balance and performance of the activities of daily living in patients with severe Multiple Sclerosis.

Entities:  

Keywords:  Multiple sclerosis; activities of daily living; balance; fatigue; gait; rehabilitation; vestibular rehabilitation

Mesh:

Year:  2018        PMID: 30412513     DOI: 10.3233/RNN-180850

Source DB:  PubMed          Journal:  Restor Neurol Neurosci        ISSN: 0922-6028            Impact factor:   2.406


  11 in total

1.  Effects of Sensory Interventions on Fatigue in People With Multiple Sclerosis: A Systematic Review.

Authors:  Mohammad Mohebbirad; Fatemeh Motaharinezhad; Mohammad Shahsavary; Ghodsiyeh Joveini
Journal:  Int J MS Care       Date:  2021-05-24

2.  Fampridine in multiple sclerosis patients with acute phase of cervical transverse myelitis: a double-blind, randomized placebo-controlled trial.

Authors:  Ali Amini Harandi; Hossein Pakdaman; Faezeh Karamiani; Faezeh Mohammadi; Siavash Shirzadeh Barough; Fatemeh Siavoshi; Saba Ilkhani; Mohammadali Sahraian
Journal:  Neurol Sci       Date:  2022-09-12       Impact factor: 3.830

3.  Evaluation of the Psychometric Properties of the Revised Piper Fatigue Scale in Patients with Multiple Sclerosis.

Authors:  Anna Berardi; Giulia Graziosi; Gina Ferrazzano; Laura Casagrande Conti; Maria Grazia Grasso; Marco Tramontano; Antonella Conte; Giovanni Galeoto
Journal:  Healthcare (Basel)       Date:  2022-05-25

4.  Development of Arabic Version of Vestibular Disorders Activities of Daily Living Scale: Cross-Cultural Adaptation and Assessment of Psychometric Properties.

Authors:  Sarah Alshehri; Jaya Shanker Tedla; Ravi Shankar Reddy; Paul Silvian Silvian; Kanagaraj Rengaramanujam; Venkata Nagaraj Kakaraparthi; Irshad Ahmad; Khalid A Alahmari
Journal:  Med Sci Monit       Date:  2021-03-06

Review 5.  Vibrotactile-Based Rehabilitation on Balance and Gait in Patients with Neurological Diseases: A Systematic Review and Metanalysis.

Authors:  Sara De Angelis; Alessandro Antonio Princi; Fulvio Dal Farra; Giovanni Morone; Carlo Caltagirone; Marco Tramontano
Journal:  Brain Sci       Date:  2021-04-19

6.  Walking With Horizontal Head Turns Is Impaired in Persons With Early-Stage Multiple Sclerosis Showing Normal Locomotion.

Authors:  Ilaria Carpinella; Elisa Gervasoni; Denise Anastasi; Rachele Di Giovanni; Andrea Tacchino; Giampaolo Brichetto; Paolo Confalonieri; Claudio Solaro; Marco Rovaris; Maurizio Ferrarin; Davide Cattaneo
Journal:  Front Neurol       Date:  2022-01-28       Impact factor: 4.003

7.  Feasibility and safety of an immersive virtual reality-based vestibular rehabilitation programme in people with multiple sclerosis experiencing vestibular impairment: a protocol for a pilot randomised controlled trial.

Authors:  Cristina García-Muñoz; María Jesús Casuso-Holgado; Juan Carlos Hernández-Rodríguez; Elena Pinero-Pinto; Rocío Palomo-Carrión; María-Dolores Cortés-Vega
Journal:  BMJ Open       Date:  2021-11-22       Impact factor: 2.692

8.  Evaluation of the Psychometric Properties of Jebsen Taylor Hand Function Test (JTHFT) in Italian Individuals With Multiple Sclerosis.

Authors:  Anna Berardi; Giovanni Galeoto; Federica Pasquali; Viola Baione; Sebastiano Giuseppe Crisafulli; Marco Tofani; Matteo Tartaglia; Giovanni Fabbrini; Antonella Conte
Journal:  Front Neurol       Date:  2022-03-18       Impact factor: 4.003

Review 9.  Effectiveness of Vestibular Training for Balance and Dizziness Rehabilitation in People with Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Authors:  Cristina García-Muñoz; María-Dolores Cortés-Vega; Alberto Marcos Heredia-Rizo; Rocío Martín-Valero; María-Isabel García-Bernal; María Jesús Casuso-Holgado
Journal:  J Clin Med       Date:  2020-02-21       Impact factor: 4.241

10.  Vestibular rehabilitation in multiple sclerosis: study protocol for a randomised controlled trial and cost-effectiveness analysis comparing customised with booklet based vestibular rehabilitation for vestibulopathy and a 12 month observational cohort study of the symptom reduction and recurrence rate following treatment for benign paroxysmal positional vertigo.

Authors:  J Marsden; M Pavlou; R Dennett; A Gibbon; R Knight-Lozano; L Jeu; C Flavell; J Freeman; D E Bamiou; C Harris; A Hawton; E Goodwin; B Jones; S Creanor
Journal:  BMC Neurol       Date:  2020-11-27       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.